gavreto
roche registration gmbh - pralsetinib - carcinom, pulmonar non-celulă mică - agenți antineoplazici - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
lunsumio
roche registration gmbh - mosunetuzumab - limfom, folicular - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
vabysmo
roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmologice - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - agenți antineoplazici - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
ocrevus 300 mg/10 ml concentrat pentru soluţie perfuzabilă
f.hoffmann-la roche, ltd. - ocrelizumab - concentrat pentru soluţie perfuzabilă - 300 mg/10 ml
pulmozyme 2500 u/2,5 ml soluţie de inhalat prin nebulizator
f.hoffmann-la roche, ltd. - dornase alfa - soluţie de inhalat prin nebulizator - 2500 u/2,5 ml
casirivimab/imdevimab 120 mg/ml +120 mg/ml concentrat pentru solutie perfuzabila
roche registration gmbh - germania - casirivimabum+imdevimabum - conc. pt. sol. perf. - 120mg/ml+120mg/ml
madopar depot
roche pharma ag - germania - combinatii (levodopum+benserazidum) - caps. elib. modif. - 100mg+25mg - agenti dopaminergici dopa si derivati
alecensa 150mg
roche pharma ag - germania - alectinib - caps. - 150mg - inhibitori de protein-kinaza
avastin 25mg/ml
roche pharma ag - germania - bevacizumabum - conc. pt. sol. perf. - 25mg/ml - anticorpi monoclonali si conjugati anticorp medicament inhibitori vegf/vegfr